News Repligen Corporation

Equities

RGEN

US7599161095

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
157.1 ^USD	-2.44%		-10.80%	-12.65%

Apr. 08	RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating	MT
Mar. 20	Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Repligen to Report First Quarter 2024 Financial Results	Apr. 17	AQ
RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating	Apr. 08	MT
Repligen : Investor Presentation April 2024 Presentations	Apr. 01	PU
Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM	Mar. 20
Repligen Appoints Maggie A. Pax to Board of Directors	Mar. 19	AQ
Repligen Corporation Appoints Maggie A. Pax as Board of Directors	Mar. 19	CI
Repligen Insider Sold Shares Worth $681,348, According to a Recent SEC Filing	Mar. 13	MT
Repligen Insider Sold Shares Worth $3,298,632, According to a Recent SEC Filing	Mar. 12	MT
Repligen Insider Sold Shares Worth $866,204, According to a Recent SEC Filing	Feb. 27	MT
UBS Adjusts Repligen Price Target to $225 From $211, Maintains Buy Rating	Feb. 22	MT
Deutsche Bank Adjusts Repligen Price Target to $180 From $175, Maintains Hold Rating	Feb. 22	MT
RBC Raises Price Target on Repligen to $225 From $200, Keeps Outperform Rating	Feb. 22	MT
Sector Update: Health Care Stocks Flat to Lower Premarket Wednesday	Feb. 21	MT
Sector Update: Health Care	Feb. 21	MT
Transcript : Repligen Corporation, Q4 2023 Earnings Call, Feb 21, 2024	Feb. 21
Repligen Q4 Adjusted Earnings, Revenue Decline; Issues 2024 Guidance; Shares Fall Premarket	Feb. 21	MT
Sartorius falls - outlook from Repligen disappointed	Feb. 21	DP
Repligen: Q4 Earnings Snapshot	Feb. 21	AQ
(RGEN) REPLIGEN CORPORATION Expects Fiscal Year 2024 EPS Range $1.42 - $1.49	Feb. 21	MT
Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 Revenue $155.7M, vs. Street Est of $156.3M	Feb. 21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Repligen Corporation

Equities

RGEN

US7599161095

Summary

Filters